News + Insights

Featured article

Hemp and CBG: What Will The 2020 Consumer Look Like?

Cannabigerol (CBG) is a rising star within the hemp industry, tipped to follow in the footsteps of CBD as the next non-psychoactive cannabinoid to dominate the low-THC consumer market.

Knowledge Is Power: Research as a Driving Force for Cannabis Reform

The number of states, territories and countries with legal cannabis policies continues to grow year-on-year, and health agencies around the world are now granting approvals for various medical cannabis products....

Prohibition Partners LIVE brings together thousands of delegates from every corner of the globe

Key Insights from The Oceania Cannabis Report: Second Edition

The Oceania Cannabis Report: Second Edition is the most extensive review of the cannabis sector in Australia, New Zealand and the surrounding islands. Launched last week, the report offers an...

Prohibition Partners: Oceania cannabis market could be worth US$1.55b

The legal cannabis market in Australia, New Zealand and the rest of Oceania is set to be worth $US1.55 billion by 2024, according to new research from leading cannabis market...

COVID-19: The turning point for global cannabis legalisation

As of Friday, 3 April 2020, there are over one million confirmed cases of coronavirus worldwide. Analysts from the IMF and UN are predicting a global recession will follow in...

INSIGHT: How COVID-19 Is Impacting The Cannabis Industry

As of 27 March, we have seen over 530,000 confirmed cases of coronavirus (COVID-19) across 199 countries. As the outbreak develops, Prohibition Partners is monitoring the situation and reporting on...

INSIGHT: The Coronavirus Pandemic and Cannabis Consumer Behaviour

As of 19 March 2020, the coronavirus (COVID-19) disease has swept through 169 countries, resulting in over 200,000 confirmed case reports worldwide. It has become the first disease outbreak since...

Prohibition Partners Releases PSYCH: The Psychedelics as Medicine Report

Leading cannabis market intelligence and strategic consultancy firm Prohibition Partners has today launched PSYCH: The Psychedelics as Medicine Report. The report is the latest in Prohibition Partners' suite of market-leading...

Key Insights from PSYCH: The Psychedelics as Medicine Report

After decades of association with the ‘hippie’ counterculture movement, psychedelics are now experiencing a period of renaissance, as the medical community investigates their potential use in treating a wealth of...

Key Insights from The European Cannabis Report: 5th Edition

The European Cannabis Report: 5th Edition is the most extensive review of the European cannabis sector published to date. Launched last week, the report contains in-depth analyses of the countries...

Is the slow pace of cannabis legalisation fuelling the black market?

Advanced research, clinical trials and passionate patients campaigns has helped to progress medical cannabis legislation on a global scale. Yet despite this, patients are seemingly continuing to turn to unregulated,...

Key Insights from The Impact Series: Disrupting Beauty

CBD cosmetics are turning heads inside the beauty industry, becoming the most disruptive force in the industry in the last two decades. The skyrocketing demand for CBD beauty products is...

Our Top Trend for 2020: Cannabis Normalisation

At the end of last year, Prohibition Partners published an analysis of the cannabis trends that shaped 2019, and offered an assessment of what we might expect from the year...

Prohibition Partners to co-host Davos’ Cannabis Conclave 2020

Prohibition Partners is pleased to be co-hosting the second annual Cannabis Conclave in Davos, Switzerland, in partnership with the Consumer Choice Center. 

The cannabis trends that shaped 2019

In 2019 Prohibition Partners identified five mega trends that were shaping the international cannabis industry.

The UK Cannabis Report: Key Insights

To mark the anniversary of the United Kingdom legalising medicinal cannabis one year ago, Prohibition Partners has produced The UK Cannabis Report. The report examines the future challenges and opportunities...

Uncovering the Truth Behind The Global Cannabis Industry Slump

With stocks in the cannabis industry climbing to record highs at the end of last year, 2019 was supposed to be the most prosperous year yet for the cannabis industry....

Key insights from The New Normal Report

The New Normal Report: Signs of the Times’ launched yesterday, in association with Protein Agency, an exploratory report documenting the rise of cannabis and CBD products across a number of...

US Congressional Committee Approves Cannabis Legalisation Bill in Historic Vote

On Wednesday, 20 November, the Marijuana Opportunity Reinvestment and Expungement (MORE) Act was passed through the House Judiciary Committee in the US, marking the first time that a congressional committee...

Key Insights from The Global Cannabis Report

The global legal cannabis market is forecast to be worth up to US$103.9 billion by the year 2024, driven, in the most part, by the burgeoning international medicinal cannabis market,...

The Germany Cannabis Report: Key Insights

Since legalising medical cannabis in 2017, Germany has become a leading power in the European cannabis industry and is set to become a behemoth in the global market in the...

The SAFE Banking Act passes the U.S House of Representatives

Earlier this month, The Secure and Fair Enforcement Banking Act was passed by the U.S House of Representatives. Here's what it means...

Zenabis CEO, Andrew Grieve, on North America cannabis market growth

Earlier this month, Zenabis Global supported Prohibition Partners with the launch of The North American Cannabis Report. The report arrives against a backdrop of increased transatlantic trade, regulatory change and...

Key learnings from The Cannabis Legal Report

The Cannabis Legal Report launches today against a backdrop of global regulatory change, as the international cannabis market begins to enter the mainstream. However, in a market worth a potential...

Greece green lights 26 medicinal cannabis licences

Greece has approved 26 licences for cannabis cultivation and processing facilities in the country, the government has confirmed.

Liberté, Égalité…Legality? French government edges towards cannabis reform

Last month one of France’s most influential think-tanks, the Conseil d’analyse économique (CAE), recommended not only that France legalise recreational cannabis use, but also that the government form a monopoly...

Gaps remain in Irish pilot programme despite first shipment of medical cannabis oil

Earlier this week, Tilray successfully delivered the first medical cannabis oil shipment to Ireland following the decision to launch a five-year medical cannabis access scheme.

Aurora wins race for Italian medical cannabis tender

Aurora Deutschland is on the brink of landing a government contract to supply medical cannabis to the Italian government, after the other three firms left in the running were eliminated...

Turkey cannabis cultivation targets international drug trafficking

Sitting on the fence between the gardens of Europe and Asia, Turkey is still streets away from the more liberal drug policies of its European neighbours. The good news for...

UK medicinal cannabis policy ‘failing patients’

MPs have said that the UK government is failing patients who are at risk and suffering without access to medicinal cannabis. They are calling for a full inquiry into the...

Capital & Cannabis Conference Europe arrives in London

Prohibition Partners has teamed up with IMN to host the first European Cannabis Capital Conference (IC3) next week, bringing together the industry’s top brands and thought leaders with an array...

Italy announces new medical cannabis tender

Update (10 July 2019): The four companies now under review by the Italian Military are Tilray, Medicinal Organic Cannabis Australia, Aurora and Canopy Growth. The companies in the tender are...

Italy’s top court bans cannabis light sales as sector feels political heat

Italy’s highest court has outlawed cannabis light sales, in a landmark ruling handed down on Thursday, stating it is a crime to market derivatives of cannabis.

Cannabis Patent Races: The rush to trademark nature

The race to patent intellectual property is a key mark of any emerging market, with patents widely recognised as the most viable way of securing future earnings and gaining a...

Three things we learned from The Asian Cannabis Report™

Asia’s medical cannabis market will be worth over US$5.8 billion by 2024 if a number of key markets introduce reform in the medium term. The figure comes from research gathered...

German cannabis cultivation licences awarded to Aphria, Aurora and Demecan

Germany has awarded three companies licences to cultivate medicinal cannabis, bringing the long-delayed tendering process that has stymied Europe’s largest market to an end.

Israeli cannabis market heats up as elections approach

“The cannabis industry is at a unique turning point, turning within a dramatically short time-frame from a pariah to a main-stage industry. Some 35 countries have already legalised cannabis to...

Lesotho cannabis licences, one small nation leading the African continent

In 2017 the Kingdom of Lesotho was the first African nation to legalise the cultivation and export of medical cannabis. As of next month it is set to issue its...

Africa cannabis market could be worth over $US 7.1 billion annually by 2023

Africa’s legal cannabis industry could be worth more than $US 7.1 billion annually by 2023 if legislation is introduced in a number of the continent’s major markets, according to research...

Brexit takes a new turn – but what lies ahead for the UK cannabis industry?

With Parliament voting down both Theresa May’s negotiated deal with the EU and the prospect of a no-deal exit, the UK will now endure a further period of prolonged commercial...

South African cannabis compromise over deadlock

In September 2018, the Constitutional Courts of South Africa legalised the private use of recreational cannabis. The move went against government policy and the executive branch of the government has...

Four key learnings from Cannabis Europa Paris

On Friday 8th February, Cannabis Europa Paris brought together leading voices on medical cannabis from the worlds of politics, pharmaceuticals and industry to discuss developments in France and across Europe.

Greek cannabis market yet to deliver as firms remain stuck

Greece’s government has been busy approving the first wave of licences for companies wanting to grow medicinal cannabis in the Hellenic Republic, but no business has yet acquired all three...

ECH, Grow and IPS create historic milestone

ECH, Grow Biotech and IPS Specials have created a historic milestone by importing the first bulk shipment of cannabis-based medicine to the UK, since the Home Office legalised medical cannabis...

Prohibition Partners recruit french regulatory advisor as tides turn on french cannabis debate

Prohibition Partners is delighted to announce that Paula Cazes will be joining the team as Regulatory Advisor and correspondent on the French cannabis market. Paula is an international lawyer, trained...

UK medicinal cannabis use hampered by lack of doctor training

The European Cannabis Report™ 4th Edition is the most extensive review to date of the European cannabis industry. It examines legislation, regulation, market size and market opportunities in 33 European...

Cannabis Europa to unlock French medical cannabis industry

Following a string of key developments in 2018, France has begun reviewing their existing conservative cannabis policy by establishing a committee to review the legal status of the medical cannabis...

UK medical cannabis is now legal, but what can we expect?

Medical cannabis is officially available in the UK today via prescription and millions of patients, who suffer from registered conditions that can be treated with cannabis, could qualify for treatment.

European presence expanded in Spanish cannabis capital

Prohibition Partners is delighted to launch its first overseas office in Barcelona, Spain. The office is run by Head of Consulting David Attwood, who recently joined the team and will...

Australia medical cannabis industry & New Zealand to take on the global market

Oceania is poised for big things in the global cannabis market with a regional industry that is estimated to be worth US$8.7 billion by 2028. With over 20 companies registered...

Canada makes history as first G7 country to fully legalise cannabis

It’s hard to think about a more significant date, in the long and arduous history of cannabis prohibition than October 17th, 2018. Today, Canada becomes the first G7 country in...

Latin America cannabis industry to be worth over $12.7 billion

Over the past 24 months, the Latin American cannabis industry has emerged from the shadows to command the attention of the international cannabis community as over ten major markets have...

High consumption and favourable legislation boost Italian cannabis market

As of September 2018, the Italian medical cannabis system is struggling to meet patient demand. In 2017, 300 patients applied for medical cannabis but, a year later, nearly 10,000 patients...

Regional complexity inhibiting the Spanish cannabis industry

Last year we examined the state of cannabis clubs in Catalonia. Historically a frontrunner in terms of both medical and recreational cannabis the region has blazed a trail in continental...

European legal cannabis market expected to exceed 115 BILLION by 2028

By 2028, the European cannabis market will be worth €115.7 billion, according to market intelligence and strategic consultancy firm, Prohibition Partners. The findings come from The 3rd Edition of The...

Cannabis Patient boom in Germany puts pressure on supply

Since March 2017, medical cannabis has been legal in Germany, launching a new domestic industry, and attracting the watchful eye of the global cannabis community. Previously, the state had only...

Dutch cannabis sector to take control back from the black market

Dutch cannabis laws are not without fault. Since the introduction of coffee shops in 1976, Amsterdam’s cannabis has been supplied by criminal organisations. Additionally, a lack of cannabis cultivation licences,...

Macedonia cannabis aims to become leading european cultivator

In February 2016, after six months of deliberation, Macedonia has pushed through legislation to legalise the use of medical cannabis. Since then Macedonia has set its sights on European expansion...

Government giving mixed signals on medical Romania cannabis legislation

Romania’s history has been full of rebounds, ebbs and flows of distress and productivity, often playing catch up to rejoin the socio-economic norms of mainstream Europe. Once a powerful hemp...

Cautious pilot scheme rolls out Luxembourg cannabis

Luxembourg, nestled between France, Belgium and Germany, has long suffered from the domination of neighbouring countries. The end result is a proud national motto “Mir wëlle bleiwe wat mir sinn”...

Turkey cannabis cultivation aims to combat international drug trafficking

Sitting on the fence between the gardens of Europe and Asia, Turkey is still streets away from the more liberal drug policies of its European neighbours. The good news for...

Cultivation laws inhibiting Slovenian cannabis treatments

Cannabis is regularly or occasionally used by 15 percent of Slovenian population and it’s estimated that 30,000 citizens self-medicate using cannabis extracts. However, only 160 patients choose to do so...

Serbian patients fight for cannabis reform

Serbia is the largest and most populous country of the former Yugoslavia. It is home to a strong pro-legalisation movement which is led by activists, patients and researchers. In this...

Portuguese Cannabis laws are holding back economic potential

Historically, Portugal is regarded as somewhat of a trailblazer when it comes to drug reform. Yet in the 15+ years that have followed, very little progress has been made and...

Is the Netherlands cannabis industry falling behind?

The New Opium Act was implemented in the Netherlands in 1976, which was to lead the way for the so called ‘Policy of Tolerance’. Initially, the policy was meant as...

British cannabis market could still dominate Europe’s legal industry

It is 50 years since the Summer of Love attempted to break down British cannabis prohibition. Thankfully the world's understanding and education of this hugely important plant has evolved significantly...

The Israel cannabis sector, a global leader

Israel has been a pioneer in the research and development of medical cannabis for decades. THC and the endocannabinoid system were first discovered there.

Is the French Cannabis sector falling behind Europe?

Eoin Keenan

What does the future hold for the Czech cannabis industry?

Eoin Keenan

Ireland cannabis legalisation hits roadblock in pursuit of medical classification

A Bill calling for the legalisation of medical cannabis in Ireland was rejected by the Oireachtas Health Committee in July over fears that it could potentially “decriminalise the recreational use...

Cannabis cigarettes.. a hit for Swiss supermarket chain

Coop, the Swiss supermarket chain, now stocks cannabis cigarettes high in CBD and initial sales have already been incredibly high.

Poland passes bill to legalise medical cannabis

Poland’s lower house of parliament (Sejm) has voted overwhelmingly in favour of making medical cannabis legal “under certain circumstances”.

Greece legalises cannabis for medical use

On June 30th, the Greek Prime Minister, Alexis Tsipras and Health Minister, Andreas Xanthos announced that Greece is to become the seventh European country to legalise cannabis for medical use.

Spanish region blazes the trail for cannabis legalisation

Following a petition which amassed over 60,000 signatures, the Catalonian Parliament decided to legalise the cultivation, consumption and distribution of cannabis throughout the autonomous Spanish region.

German Cannabis leads the European medical market

January 19th, 2017 saw a major development in Germany’s relationship with cannabis. German parliament unanimously voted to make it legal for doctors to prescribe cannabis-based treatments for ‘seriously ill’ patients.

The European Cannabis Report

The legal cannabis industry is the biggest potential new market in the world, with Europe’s recreational alone currently being valued at €18bn. The European Cannabis Report from Prohibition Partners is the first...

Could Italy fully legalise recreational cannabis use? [And what could it mean for the economy?]

In April, in an effort to develop attitudes towards cannabis even further, The Radicali Italiani Movement announced plans to introduce a bill that proposes the full legalisation of adult cannabis...

news

intelligence

insights

on the cannabis market

Our weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry.